Quest falls after warning of $25 million hit to Q1 revenue

Lab operator Quest Diagnostics' DGX.N shares fall 4.5% to $164.73

Co says it expects headwind to revenue of about $25 mln and to EPS of about 10 cents in Q1 2025 due to "worse-than-anticipated weather"

Earlier this year, ExamOne, a Quest subsidiary, said it faced disruptions to its operations, including temporary closures of Patient Service Centers (PSCs) and shipping delays due to severe winter weather across the US

Quest has 2,250 PSCs across the US where people can get blood tests and other medical samples collected

DGX gained 33.7% in the last 12 months